Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 6/20 | 0.42 |
| ▸ | TYMP | P19971 | 2/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.32 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9391435 | 0.89 | RNASE1 (0.43) | TYMSRNASE1 | |
| SCHEMBL9393718 | 0.86 | TYMP (0.37) | TYMPP2RY2P2RY4 | |
| SCHEMBL9393004 | 0.83 | TYMP (0.47) | TYMPP2RY2P2RY4 | |
| SCHEMBL30820589 | 0.83 | DUT (0.37) | DUTTYMPP2RY14TYMSP2RY2 | |
| SCHEMBL19840575 | 0.82 | DUT (0.43) | DUTTYMPP2RY14TYMSMEN1 | |
| SCHEMBL14062471 | 0.80 | DUT (0.47) | DUTTYMPP2RY14TYMSMEN1 | |
| SCHEMBL9391408 | 0.80 | TYMP (0.44) | TYMP | |
| SCHEMBL19841219 | 0.80 | DUT (0.60) | DUTTYMPP2RY14TYMSP2RY2 | |
| SCHEMBL912656 | 0.80 | DUT (0.60) | DUTTYMPP2RY14TYMSP2RY2 | |
| SCHEMBL14403996 | 0.80 | DUT (0.60) | DUTTYMPP2RY14TYMSP2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0691981-A1 | TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994020523-A1 | TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-09-15 | — | — | WO | disclosed |